Particle.news
Economic Indicators Stock Performance Stock Market Risk Assessment Investor Behavior Investor Sentiment Sector Performance Risk Management Economic Forecasts Trading Strategies
It converts sellers' future value into milestone‑contingent rights worth up to $2.50 per share, tied to Phase 3 starts, U.S. approvals, DEA rescheduling.
